Cargando…
Bioavailability of Orally Administered Drugs in Critically Ill Patients
Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350721/ https://www.ncbi.nlm.nih.gov/pubmed/35521821 http://dx.doi.org/10.1177/08971900221100205 |
_version_ | 1785074203946385408 |
---|---|
author | Forsberg, Johanna Bedard, Emma Mahmoud, Sherif H. |
author_facet | Forsberg, Johanna Bedard, Emma Mahmoud, Sherif H. |
author_sort | Forsberg, Johanna |
collection | PubMed |
description | Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in unadjusted doses thereby putting the patients at a risk for therapy failure. The objective for this study was to summarize the available evidence regarding oral drug absorption in the ICU. A literature search of the databases MEDLINE, EMBASE, and PubMed was conducted on (February 24, 2020). Articles discussing the rate and/or extent of orally administered drugs in critically ill patients were included. A total of 58 studies were found: 17 interventional studies, 33 observational studies (30 prospective, 3 retrospective) and 8 case reports. A total of 43 articles reported altered drug absorption in critically ill patients suggesting the need for alternative measures to facilitate treatment success. The absorption of orally administered drugs may be altered in critically ill patients. Measures for altered drug absorption in critically ill patients were suggested such as holding tube feeding before and after medication administration, increasing doses of orally administrated drugs and using alternate routes of administration. |
format | Online Article Text |
id | pubmed-10350721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-103507212023-07-18 Bioavailability of Orally Administered Drugs in Critically Ill Patients Forsberg, Johanna Bedard, Emma Mahmoud, Sherif H. J Pharm Pract Review Articles Critically ill patients managed in the Intensive Care Unit (ICU) suffer from several pathophysiological alterations due to critical illness resulting in potential changes in the pharmacokinetics of drugs including systemic absorption. Nevertheless, these patients are still given some medications in unadjusted doses thereby putting the patients at a risk for therapy failure. The objective for this study was to summarize the available evidence regarding oral drug absorption in the ICU. A literature search of the databases MEDLINE, EMBASE, and PubMed was conducted on (February 24, 2020). Articles discussing the rate and/or extent of orally administered drugs in critically ill patients were included. A total of 58 studies were found: 17 interventional studies, 33 observational studies (30 prospective, 3 retrospective) and 8 case reports. A total of 43 articles reported altered drug absorption in critically ill patients suggesting the need for alternative measures to facilitate treatment success. The absorption of orally administered drugs may be altered in critically ill patients. Measures for altered drug absorption in critically ill patients were suggested such as holding tube feeding before and after medication administration, increasing doses of orally administrated drugs and using alternate routes of administration. SAGE Publications 2022-05-06 2023-08 /pmc/articles/PMC10350721/ /pubmed/35521821 http://dx.doi.org/10.1177/08971900221100205 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Articles Forsberg, Johanna Bedard, Emma Mahmoud, Sherif H. Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title | Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title_full | Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title_fullStr | Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title_full_unstemmed | Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title_short | Bioavailability of Orally Administered Drugs in Critically Ill Patients |
title_sort | bioavailability of orally administered drugs in critically ill patients |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350721/ https://www.ncbi.nlm.nih.gov/pubmed/35521821 http://dx.doi.org/10.1177/08971900221100205 |
work_keys_str_mv | AT forsbergjohanna bioavailabilityoforallyadministereddrugsincriticallyillpatients AT bedardemma bioavailabilityoforallyadministereddrugsincriticallyillpatients AT mahmoudsherifh bioavailabilityoforallyadministereddrugsincriticallyillpatients |